Falconer Ester 4
4 · AbCellera Biologics Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Falconer Ester
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Shares
2021-09-01$16.89/sh+875,000$14,778,750→ 875,000 total - Exercise/Conversion
Share option (right to buy)
2021-09-01−875,000→ 875,000 totalExercise: $0.31Exp: 2029-01-01→ Common Shares (875,000 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on January 1, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date